Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Jun 11 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 15,294 | — | — | +91.9% | Open the original filing on SEC.gov |
| May 29 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 1,262 | $8.91 | $11.2K | +8.2% | Open the original filing on SEC.gov |
| Feb 27 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 528 | $8.75 | $4.6K | +3.5% | Open the original filing on SEC.gov |
| Jan 23 | ATXS | Astria Therapeutics, Inc. | DTOISS◆ | 761,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 23 | ATXS | Astria Therapeutics, Inc. | DTOISS◆ | 195,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 23 | ATXS | Astria Therapeutics, Inc. | DTOISS | 4,377 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jan 23 | BCRX | Biocryst Pharmaceuticals… | AGRANT◆ | 26,684 | — | — | — | Open the original filing on SEC.gov |
| Jan 23 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 12,272 | — | — | +475.3% | Open the original filing on SEC.gov |
| Jan 23 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 2,582 | — | — | — | Open the original filing on SEC.gov |